In this work, we study the critical behavior of an epidemic propagation model that considers individuals that can develop drug resistance. In our lattice model, each site can be found in one of four states: empty, healthy, normally infected (not drug resistant) and strain infected (drug resistant) states. The most relevant parameters in our model are related to the mortality, cure and mutation rates. This model presents two distinct stationary active phases: a phase with coexisting normal and drug resistant infected individuals and an intermediate active phase with only drug resistant individuals. We employ a finite-size scaling analysis to compute the critical points the critical exponents ratio β/ν governing the phase-transitions between these active states and the absorbing inactive state. Our results are consistent with the hypothesis that these transitions belong to the directed percolation universality class.
I. INTRODUCTION
The spread of epidemic processes in a population has been profusely studied by biologically oriented mathematicians mainly by the use of a set of partial differential equations governing the time evolution of global variables such as the density of infected, refractory and healthy individuals [1] . At high dimensions where local density fluctuations are negligible, this mean-field like approach gives the correct overall behavior of these systems, according to renormalization group arguments. At low dimensions, density fluctuations become relevant and microscopic approaches have to be considered. In general, most models of epidemic propagation processes present a second order phase transition between a vacuum and a stationary active state [2, 3, 4, 5, 6] . The vacuum corresponds to an absorbing state towards which the system can evolve but from which it cannot leave. Systems with such absorbing states cannot satisfy detailed balance due to the irreversible character of their dynamics.
Nonequilibrium phase transitions from active fluctuating into inactive absorbing states have been studied extensively for the last twenty years [3, 7, 8, 9, 10, 31] . These phase transitions into absorbing states are characterized by a nonequilibrium critical behavior similar to that of an equilibrium phase transition in many respects. One usually uses the concept of scale invariance to understand nonequilibrium phase transitions with critical exponents characterizing its universal behavior. These exponents allow us to categorize nonequilibrium phase transitions into different universality classes. In reaction models for the spread of epidemics, the density of infected individuals ρ I acts as the order parameter, vanishing in the absorbing state and having a finite average value in the active state. The transition between the active and stationary state is achieved by tuning a typical reaction rate λ that acts as the relevant control parameter. In the vicinity of the critical point, the density of infected individuals vanishes as ρ ∝ (λ − λ c ) β . Nonequilibrium phase transitions are often characterized by spatial and temporal correlation lengths. Close to the transition point, the spatial and temporal correlation lengths diverge as ξ s ∝ (λ − λ c ) −ν and ξ t ∝ (λ − λ c ) −ν ′ . These two correlation length scales are related by ξ s = ξ z t , where z = ν/ν ′ is called the dynamic exponent. These three critical exponents ( β, ν, z) form the basic set of exponents characterizing the universality class of a given reaction-diffusion process. It is generally believed that nonequilibrium phase transitions into absorbing states can be categorized into a finite number of universality classes. Usually, systems presenting a continuous transition to a single absorbing state belong to the directed percolation universality class [3, 11, 12] .
However, some exceptions to this general rule have been recently reported to occur basically in systems with a infinite number of absorbing states [13, 14, 15, 16, 17, 18] or with particle diffusion [19, 20, 21] .
In recent years, there has been a growing interest in studying diseases caused by organisms that can mutate into drug resistant forms. One of the major reasons for the emergence of such resistant organisms is the inappropriate use of the drugs used to combat them. Such is the case, for example, when antibiotics are incorrectly administered to treat the tuberculosis bacillus [22, 23] , or the excessive use of anti-malaria drugs in Amazonia, Brazil [24, 25, 26, 27, 28] . Although these drugs are the only known effective treatments for such diseases, their abuse can very quickly lead to the emergence of drug resistant mutant strains. For example, while the exact mechanisms are not fully understood, strains have evolved that are resistant to every drug used in Amazonia during the 1950's and 60's. To retard the emergence of such resistant strains, measures are now being taken in the medical profession to administer drugs only when needed, and giving preference to drug "cocktails" with multiple components [26, 27, 28] . Recently, an epidemic spreading model with immunization and mutations has been introduced [29] . The model also exhibits a phase transition belonging to the directed percolation universality class and shows explicitly that the protection gained by immunization is substantially decreased by the occurrence of mutations.
In this work, we will study a 1-dimensional stochastic epidemic propagation model considering the potential emergence of a population of drug resistant organisms. We will be mainly interested in determining the stable phases and the scaling exponents governing the possible phase transitions. The model presents two coupled order parameters, namely, the density of drug sensitive and drug insensitive individuals. The coupling of an order parameter to a fluctuating density has been shown to modify the universality class of the absorbing sate phase transition in some models of population dynamics [30, 31] . By employing extensive numerical simulations in finite populations and finite size scaling analysis, we will show that an active phase emerges in which there is no drug sensitive individuals but a finite density of drug resistant ones. The relative strength of the parameters controlling the processes of healing, death and development of drug resistance, actually determines the stationary population state. Further, we will show that all identified transitions in this model seem to belong to the directed percolation universality class.
II. BASIC MODEL FOR THE EMERGENCE OF DRUG RESISTANCE
Here, we will follow closely the ideas of [32] . Individuals distributed at random on a given environment can be in three possible states, namely healthy, infected by normal strain and infected by resistant strain. Birth of individuals will be introduced by considering that a vacant site becomes occupied by a healthy individual at a rate β 1 . Infection occurs by contact at a rate β i n i where n i is the number of infected neighbors and the index i stands for normal (i = 2) and drug resistant (i = 3) states. Individuals infected with the normal strain can heal at a rate p c . In what follows, we will consider that the healing rate is due to drug administration, i.e., the spontaneous healing rate is negligible. Infected individuals can also develop drug resistance at a rate p r . This process can be originated by both natural mutations and bad drug administration. Individuals that develop drug resistance will not be allowed to heal and die at a mortality rate p m . The average surviving-time of drug resistant individuals is much smaller than the average life-time of individuals infected with the normal strain, which will be taken as infinite in our simulations. The above dynamical rules describing the processes of birth, death, healing, development of drug resistance and infection by contact with normal or resistant strains are summarized in table 1. Notice that the state with only healthy individuals is an absorbing one, since it is no longer possible for anybody to become infected. Such is the case, for example, with small pox, which has been eradicated.
A mean field approximation can be described using the following rate equations for the average densities:
where a homogeneous, i.e., spatially uniform density of all populations was assumed. In addition to these rules, the contamination of a healthy individual that is surrounded by both kinds of infected sites is chosen to be preferentially updated to state η 3 (resistant strain).
In figure 1 , we show the equilibrium density of normally infected individuals (ρ 2 ) and drug resistant ones (ρ 3 ) as obtained from simulations on chains with L = 800 sites for three characteristic values of the mutation rate p r . We observe that the absorbing state is the equilibrium state for large values of cure and mortality rates. Two distinct active stationary regimes are also clearly identified. The first one corresponds to a state with zero density of normally infected but with a finite density of drug resistant ones. This phase is stable at low death rates and its emergence is independent of the mutation rate p r = 0. The large surviving time of drug resistant individuals in this regime favors the contamination process. The second active state has co-existing densities of normal and drug resistant infected individuals. It emerges in the regime of low cure rates but disappears for large mutation rates. A direct transition between these active states takes place at low death and cure rates.
In order to closely investigate the transition between the active state with co-existing densities and the absorbing state, we computed the order parameter densities for p c = 0 (no healing), which is the most favorable case for co-existence. In figure 2 , we show the relevant densities as function of p r and p m . Notice that there is a critical mutation rate above which the phase with co-existing densities disappears. The maximum value for the critical mutation rate is attained for p m = 1. To have an accurate estimate of the critical parameters, we employed a finite size scaling analysis of our numerical data. Figure 3 shows the density ρ 2 as a function of the mutation rate for the special case of p c = 0 and p m = 1 and several chain sizes. The data suggest a continuous transition near p r = 0.175. A numerical renormalization group analysis of the above data can provide a better estimate of the critical value. This procedure explores the finite size scaling relation that the order parameter density is expected to obey at the vicinity of the critical point, namely
Therefore, one can construct a family of auxiliary functions
According to the finite size scaling hypothesis, these auxiliary functions shall all intercept at the critical point and g(p * r ) = −β/ν. In figure 4 , we report the above scaling analysis to the data shown in figure 3 . All curves obtained from distinct pairs of lattice sizes intercept nearly at the same point. Without considering any correction to scaling, we obtain an accurate estimate of p * r = 0.176(1) and the critical exponents ratio β/ν = 0.25(1). The above finite-size scaling analysis was employed to obtain the full phase diagram in the absence of treatment (p c = 0) as shown in figure 5 . The absorbing healthy state (H) is always the equilibrium one at large mutation and mortality rates. The phase diagram exhibits three distinct phase transitions. For mortality rates above p * m = 0.224(1), the active state is the one with co-existing densities of normal (N) and resistant (R) individuals which is the stationary state at small p r . For mortality rates below p * m the stationary state is always active, as the long surviving-time of infected individuals makes the contamination process the predominant one. However, there is a transition between the active co-existing state at small p r to the active state with a finite density of drug resistant individuals and a zero density of normal individuals at large p r . Notice that at intermediate mutation rates p r the phase-diagram presents re-entrant transitions with the sequence of active-inactive-active equilibrium states appearing with increasing mortality rates p m . In all cases, the measured values of β/ν were consistent with these transitions belonging to the directed percolation universality class. In figure 6 we illustrate the main phase-diagram for a fixed mutation rate.
In this case, the absorbing state is the equilibrium state at large cure and mortality rates. At We further employed a finite-size scaling analysis to compute the exponent ratio β/ν which is consistent with these transitions belonging to the directed percolation universality class.
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This work was partially supported by the Brazilian research agencies CNPq and CAPES and by the Alagoas state research agency FAPEAL. to the absorbing (H) state takes place with increasing cure rates. In this region the absorbing state is reached through both death and cure process.
